Novel compound heterozygous mutations in the LARS2 gene in a Chinese family with hearing loss
Neurogenetics · 2025
DOI: 10.1007/s10048-024-00797-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurogenetics, 2025. Verfasst von Mengyi Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology & Head and Neck, Liuzhou Worker's Hospital of Guangxi Zhuang Autonomous Region, 156 Heping Road, Liuzhou, 545007, China. Hauptthemen laut MEDLINE: Amino Acyl-tRNA Synthetases, Gonadal Dysgenesis, 46,XX, Hearing Loss, Sensorineural. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Partial financial support was received from Guangxi Zhuang Autonomous Region Clinical Key Specialty Construction Project.
Abstract (Originalsprache)
BACKGROUND: Mutations in the LARS2 gene are correlated with Perrault syndrome, a rare autosomal recessive genetic disorder, that is typically characterized by sensorineural hearing loss and ovarian insufficiency. METHODS: Whole-exome sequencing and mutational analysis were employed to identify hearing loss-causing genes in a Chinese family from the Guangxi Zhuang Autonomous Region. Clinical phenotypes, audiological data, and color Doppler ultrasound of the family were collected, and a series of computer software were used to analyze the impact of genetic variations on protein structure and function. RESULTS: Novel compound heterozygous LARS2 variants, c.604G > A and c.703C > T, were linked to hearing loss in the family, the latter of which has not been reported in any public database. The proband and her brother in this family presented with hearing loss, while the parents had normal hearing. Additionally, the c.703C > T mutation is a nonsense mutation, leading to a significant loss of amino acids, while the c.604G > A mutation affects the secondary structure and side-chain structure of the protein. CONCLUSION: These mutations expand the LARS2 mutation spectrum and provide a basis for the genetic diagnosis of Perrault syndrome and related hearing loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology & Head and Neck, Liuzhou Worker's Hospital of Guangxi Zhuang Autonomous Region, 156 Heping Road, Liuzhou, 545007, China.
- Department of Otolaryngology & Head and Neck, Liuzhou Worker's Hospital of Guangxi Zhuang Autonomous Region, 156 Heping Road, Liuzhou, 545007, China. zhouni770@163.com.
- Department of Otolaryngology & Head and Neck, Liuzhou Worker's Hospital of Guangxi Zhuang Autonomous Region, 156 Heping Road, Liuzhou, 545007, China. lilingbo@ldy.edu.rs.
Förderung
- Partial financial support was received from Guangxi Zhuang Autonomous Region Clinical Key Specialty Construction Project
Zitieren
APA
Lu, M., Zhou, K., Yang, X., Lin, L., Lu, L., Qin, Y., Zhou, N., & Li, L. (2025). Novel compound heterozygous mutations in the LARS2 gene in a Chinese family with hearing loss. Neurogenetics. https://doi.org/10.1007/s10048-024-00797-1
Vancouver
Lu M, Zhou K, Yang X, Lin L, Lu L, Qin Y, et al. Novel compound heterozygous mutations in the LARS2 gene in a Chinese family with hearing loss. Neurogenetics. 2025. doi:10.1007/s10048-024-00797-1
BibTeX
@article{Lu2025,
author = {Lu, Mengyi and Zhou, Kai and Yang, Xiuyun and Lin, Lin and Lu, Lixiang and Qin, Yujie and Zhou, Ni and Li, Lingbo},
title = {Novel compound heterozygous mutations in the LARS2 gene in a Chinese family with hearing loss},
journal = {Neurogenetics},
year = {2025},
doi = {10.1007/s10048-024-00797-1}
}
EUVIMED